LakeShore Biopharma Co Accounts Payable

LakeShore Biopharma Co (YS) currently reports a accounts payable of $50M as of March 2025. That compares with $68M in the prior-year period — down 26.9% year over year. Use the charts on this page to explore LakeShore Biopharma Co's accounts payable history and peer comparisons.

LakeShore Biopharma Co's accounts payable decreased from $68M to $50M — a 26.9% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co reported $50M in accounts payable as of March 2025. That compares with $68M in the prior-year period — down 26.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $50M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following YS for alerts when major investors trade the stock.